Navigation Links
Neogen Forms Mexican Subsidiary
Date:6/10/2008

LANSING, Mich., June 10 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today the formation of its new subsidiary in Mexico, Neogen Latino America SPA. The new company, headquartered in Mexico City, will distribute the company's food and animal safety products throughout Mexico.

Neogen Latino America unifies Neogen's widespread business activities throughout Mexico to animal and crop producers, and food processors. The new company will also work with the United States and Mexico on programs to ensure the safety of food products that move across the border from either country. As a result of nearly 20 years of use, Neogen products have earned the trust of Mexican producers of meat and milk, and food processors.

"Much as we did earlier with the acquisition of our Scottish and German food safety distributors, we now see an opportunity to greatly strengthen our presence in Mexico," said Lon Bohannon, Neogen's president. "We believe Mexico continues to hold unrealized opportunities for sales growth."

Approximately $40 million of Neogen's FY 2008 revenue came from international sources.

Neogen's new company will start business with a revenue base of over $2 million (U.S.) that came from multiple sources in FY 2008. Jose Noriega, the former president of Biotecnologia Industrial, will manage the new company and own a minority interest.

"We are pleased to have Jose head the new company and direct our expansion," said Bohannon. "We have enjoyed a close relationship with him for 20 years as a distributor of Neogen's food safety products."

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.


'/>"/>
SOURCE Neogen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
2. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
3. Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues
4. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
5. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
6. Neogen Launches Quickest Test Available for Tetracyclines in Milk
7. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
8. Neogen Acquires Assets of Rivard Instruments
9. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
10. Neogen Acquires Kane Enterprises
11. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of ... award for Excellence in Volunteer Experience from US2020. , US2020’s mission is to ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):